Immune System Key Israeli Company
Immune System Key (ISK) is engaged in the discovery and development of treatments for malignant cancers and autoimmune diseases, with a primary focus on treating patients with acute myeloid leukemia (AML), pancreatic cancer, and triple-negative breast cancer. Its assets are based on novel human-secreted peptides that were discovered by the company's founders.
Health Tech & Life Sciences
Alternatives
No alternatives listed yet.
Suggest an Alternative
Founders
Office Locations
Jerusalem, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/immune-system-key-isk
[2]
crunchbase.com
- https://www.crunchbase.com/organization/immune-system-key
External links are provided for reference and verification purposes.